Long Non-coding RNA CTA Sensitizes Osteosarcoma Cells to Doxorubicin Through Inhibition of Autophagy
Overview
Authors
Affiliations
Recently, several long non-coding RNAs (lncRNAs) have been implicated in osteosarcoma (OS). However, the regulatory roles of lncRNAs in chemotherapy resistance of OS still remain unclear. This study aimed to screen a novel lncRNA that contributes to chemotherapeutic resistance of OS, and to explore the underlying mechanisms. Our data showed that lncRNA CTA was markedly downregulated in OS tissues compared to their matched non-tumor tissues, and low expression of lncRNA CTA was significantly associated with the advanced clinical stage and tumor size. In addition, OS patients with low lncRNA CTA levels showed a worse prognosis when compared with those with high expression of lncRNA CTA. Furthermore, we report that lncRNA CTA has an inverse relationship with miR-210 expression in OS tissues. LncRNA CTA could be activated by doxorubicin (DOX), and could promote OS cell apoptosis by competitively binding miR-210, while inhibit cell autophagy. On the other hand, lncRNA CTA was downregulated in DOX-resistant OS cells. Overexpression of lncRNA CTA reduced autophagy and subsequently overcame DOX resistance of OS in vitro and in vivo. Therefore, we demonstrate that lncRNA CTA is an essential regulator in DOX-induced OS cell apoptosis, and the lncRNA CTA-miR-210 axis plays an important role in reducing OS chemoresistance.
Kumar A, Yap K, BharathwajChetty B, Lyu J, Hegde M, Abbas M J Biomed Sci. 2024; 31(1):105.
PMID: 39716252 PMC: 11667983. DOI: 10.1186/s12929-024-01092-9.
Hu S, Han X, Liu G, Wang S Front Endocrinol (Lausanne). 2024; 15:1415722.
PMID: 39015175 PMC: 11249743. DOI: 10.3389/fendo.2024.1415722.
H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy.
Zhong C, Xie Z, Duan S Clin Transl Med. 2023; 13(10):e1445.
PMID: 37837401 PMC: 10576445. DOI: 10.1002/ctm2.1445.
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.
Zhang H, Hu Y, Deng J, Fang G, Zeng Y Front Pharmacol. 2023; 14:1243934.
PMID: 37781691 PMC: 10540237. DOI: 10.3389/fphar.2023.1243934.
Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy.
Saadh M, Almoyad M, Arellano M, Maaliw 3rd R, Castillo-Acobo R, Jalal S Cancer Chemother Pharmacol. 2023; 92(6):439-453.
PMID: 37768333 DOI: 10.1007/s00280-023-04582-z.